| P2093 | author name string | Xinguo Jiang | |
| P2860 | cites work | The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction | Q89471537 |
| | Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma | Q91473840 |
| | Involvement of chemokine receptors in breast cancer metastasis | Q24290909 |
| | Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion | Q24311291 |
| | CCR7 and its ligands: balancing immunity and tolerance | Q24316090 |
| | Functionally specialized junctions between endothelial cells of lymphatic vessels | Q24676415 |
| | Regulation of immune responses by extracellular vesicles | Q27006748 |
| | Emerging roles of lymphatic endothelium in regulating adaptive immunity | Q27686792 |
| | Tumor angiogenesis: therapeutic implications | Q27860595 |
| | The role of lymphangiogenesis and angiogenesis in tumor metastasis | Q28067309 |
| | Cancer metastases: challenges and opportunities | Q28088755 |
| | VEGF-D promotes the metastatic spread of tumor cells via the lymphatics | Q28200072 |
| | Hyperplasia of lymphatic vessels in VEGF-C transgenic mice | Q28238886 |
| | Regulation of interferon-gamma during innate and adaptive immune responses | Q28256001 |
| | Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells | Q30415907 |
| | Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes | Q30444006 |
| | CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells | Q30480094 |
| | TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice | Q30490532 |
| | Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse | Q30499924 |
| | Releasing pressure in tumors: what do we know so far and where do we go from here? A review | Q38207981 |
| | Microenvironment of tumor-draining lymph nodes: opportunities for liposome-based targeted therapy | Q38266149 |
| | Lymphatic System in Cardiovascular Medicine | Q38723399 |
| | Lymphatic Regulation of Cellular Trafficking | Q38997287 |
| | Elements of cancer immunity and the cancer-immune set point | Q39094764 |
| | Emerging Biological Principles of Metastasis | Q39130446 |
| | Lymphatic Changes in Respiratory Diseases: More than Just Remodeling of the Lung? | Q39263241 |
| | Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction | Q39954980 |
| | The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis. | Q39970530 |
| | Conduits mediate transport of low-molecular-weight antigen to lymph node follicles | Q41291427 |
| | The Lymphatic System: Integral Roles in Immunity | Q41340368 |
| | Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels | Q42146832 |
| | Human CAFs promote lymphangiogenesis in ovarian cancer via the Hh-VEGF-C signaling axis | Q42366544 |
| | Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia | Q42800633 |
| | pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription | Q42827113 |
| | FGF-dependent metabolic control of vascular development | Q43076661 |
| | TH2 cells and their cytokines regulate formation and function of lymphatic vessels | Q43705669 |
| | Interstitial flow as a guide for lymphangiogenesis | Q44353733 |
| | Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders. | Q44844173 |
| | Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response | Q44857951 |
| | Lymphatic Dysfunction, Leukotrienes, and Lymphedema. | Q46193795 |
| | CCL3 Enhances Antitumor Immune Priming in the Lymph Node via IFNγ with Dependency on Natural Killer Cells | Q47095893 |
| | Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma. | Q47678837 |
| | Lymphangiogenesis guidance by paracrine and pericellular factors | Q47744569 |
| | S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β. | Q48355741 |
| | The role of fatty acid β-oxidation in lymphangiogenesis | Q48381437 |
| | Carcinoma associated fibroblasts derived from oral squamous cell carcinoma promote lymphangiogenesis via c-Met/PI3K/AKT in vitro | Q49199965 |
| | Lymphatic Vessels: The Next Frontier in Lung Transplant | Q49847182 |
| | Three-dimensional biomimetic model to reconstitute sprouting lymphangiogenesis in vitro. | Q51473870 |
| | Cytokines regulating lymphangiogenesis. | Q52572307 |
| | ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer. | Q52663621 |
| | Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor. | Q54373383 |
| | Innate effector cells in angiogenesis and lymphangiogenesis. | Q54978725 |
| | Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. | Q55561847 |
| | Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease | Q56336013 |
| | Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self | Q57232929 |
| | Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis | Q57382204 |
| | IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin | Q58088797 |
| | Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema | Q58599373 |
| | Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy | Q60912821 |
| | CXCR4 engagement promotes dendritic cell survival and maturation | Q80748538 |
| | Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis | Q81004145 |
| | Lymph node-derived lymphatic endothelial cells express functional costimulatory molecules and impair dendritic cell-induced allogenic T-cell proliferation | Q83766820 |
| | VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics | Q84621185 |
| | Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes | Q87809290 |
| | Enhancing Renal Lymphatic Expansion Prevents Hypertension in Mice | Q87865264 |
| | Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. | Q30541916 |
| | Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma | Q30843481 |
| | Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system | Q33869764 |
| | Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy | Q33920298 |
| | Neoantigens in cancer immunotherapy. | Q34470074 |
| | Lymphatic vessels in cancer metastasis: bridging the gaps | Q34511039 |
| | Leukotriene B4 antagonism ameliorates experimental lymphedema | Q34556483 |
| | VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites | Q35616124 |
| | Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells | Q35758725 |
| | Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival | Q35791518 |
| | Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways | Q35964906 |
| | Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks | Q36007057 |
| | Lymph node biophysical remodeling is associated with melanoma lymphatic drainage | Q36171323 |
| | Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation | Q36228510 |
| | PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells | Q36241115 |
| | Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis | Q36241623 |
| | Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes | Q36278300 |
| | VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis | Q36403416 |
| | Transgenic overexpression of interleukin-1β induces persistent lymphangiogenesis but not angiogenesis in mouse airways | Q36750145 |
| | Molecular mechanisms of lymphatic vascular development | Q36801434 |
| | The immune system and inflammation in breast cancer | Q37033451 |
| | Lymphatic vessels regulate immune microenvironments in human and murine melanoma | Q37217526 |
| | Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease | Q37413735 |
| | Lymphatic endothelial cells attenuate inflammation via suppression of dendritic cell maturation | Q37457544 |
| | New developments in clinical aspects of lymphatic disease | Q37609636 |
| | Mechanisms of lymphatic metastasis | Q37609660 |
| | Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation | Q37622038 |
| | Bidirectional Crosstalk between Lymphatic Endothelial Cell and T Cell and Its Implications in Tumor Immunity | Q37625551 |
| | Lymphangiogenesis: Molecular mechanisms and future promise | Q37697245 |
| | Molecular mechanisms and imaging of lymphatic metastasis | Q38090228 |
| | Lymphatic vessels in the development of tissue and organ rejection | Q38166268 |
| | Regulatory T cells in cancer immunotherapy | Q38177627 |
| | Lymphangiogenesis and lymphatic vessel remodelling in cancer | Q38190359 |
| | Lymphangiogenic factors, mechanisms, and applications | Q38192927 |
| P921 | main subject | tumor metastasis | Q120912381 |
| P577 | publication date | 2019-07-12 | |
| P1433 | published in | Journal of Zhejiang University. Science. B | Q15762056 |
| P1476 | title | Lymphatic vasculature in tumor metastasis and immunobiology | |